GALAPAGOS N.V. | 88.420 / -1.86% |
Date/Time | 01/28 / 13:43 |
Chg. / Chg.(%) | -1.680 / -1.86% |
Bid | 88.220 / 113 |
Ask | 88.320 / 113 |
Open | 90.100 |
Previous Close | 90.100 |
High | 90.100 |
Low | 87.480 |
Volume [EUR] | 5,187.020 |
Volume [Units] | 59 |
Price fixings | 10 |
ISIN | BE0003818359 |
Security | GXE |
Exchange | gettex |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - A.. | 88.44 | ![]() |
181,135 |
Cboe Europe .. | 88.46 | ![]() |
26,802 |
London Inter.. | 88.36 | ![]() |
10,308 |
Turquoise | 88.52 | ![]() |
8,597 |
TradeGate | 88.42 | ![]() |
356 |
gettex | 88.420 | ![]() |
59 |
Frankfurt | 89.9200 | ![]() |
2 |
Cboe Europe .. | 87.70 | ![]() |
1 |
Düsseldorf | 87.52 | ![]() |
0 |
München | 90.20 | ![]() |
0 |
Berlin | 88.32 | ![]() |
0 |
Vienna Globa.. | 88.84 | ![]() |
0 |
Lang & Schwa.. | 88.38 | ![]() |
|
Stuttgart | 87.720 | ![]() |
|
Cboe Europe .. | 90.36 | 109 | |
Nasdaq Other.. | 110.1000 | ![]() |
58 |
Xetra | 90.60 | 15 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
01/20/2021 / 08:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
01/07/2021 / 08:00 - GlobeNewswire - Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:30 - GlobeNewswire
Personal area
Click on
to activate push quotes.
